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ABSTRACT
Background: Visceral obesity is closely associated with cardiovas-
cular disease and the metabolic syndrome. Estimating the amount of
visceral fat is important and requires a straightforward, reliable, and
practical method.
Objective: We investigated whether visceral fat thickness (VFT)
measured by ultrasonography can adequately assess visceral fat ac-
cumulation and predict cardiovascular or metabolic diseases.
Design: Diabetic patients (240 men and 106 women) underwent
ultrasonography to estimate visceral fat accumulation.
Results: The visceral adipose tissue area had the best correlation
with VFT (r  0.799, P  0.001). VFT correlated with HDL-
cholesterol, triacylglycerol, and high-sensitivity C-reactive protein
concentrations, the homeostasis model assessment for insulin resis-
tance, and the intima-media thickness at the common carotid artery
(r  0.30, 0.39, 0.34, 0.31, and 0.33, respectively; P  0.05) in
men and with triacylglycerol and high-sensitivity C-reactive protein
concentrations and the homeostasis model assessment for insulin
resistance (r  0.33, 0.44, and 0.30, respectively; P  0.05) in
women. Men in the middle and high VFT tertiles had a higher odds
ratio (OR) of coronary artery disease [ORs: 4.48 (95% CI: 1.29, 5.51)
and 2.04 (1.06, 3.94), respectively; P 0.016], hypertriacylglycer-
olemia [ORs: 2.87 (1.41, 5.86) and 1.91 (1.24, 2.95), respectively;
P 0.003], and the metabolic syndrome [ORs: 3.38 (1.61, 7.10) and
1.95 (1.16, 3.27), respectively; P 0.003] than did those in the low
tertile, after adjustment for age, waist circumference, and body mass
index.
Conclusion: VFT might be a reliable index for assessing the amount
of visceral fat and for identifying diabetic patients, particularly men,
who are at high risk of cardiovascular disease. Am J Clin Nutr
2004;79:593–9.
KEY WORDS Abdominal obesity, cardiovascular disease,
coronary artery disease, ultrasonography, visceral fat, waist circum-
ference
INTRODUCTION
Obesity has induced many public health problems related to
metabolic diseases, including glucose intolerance, hypertension,
dyslipidemia, hyperinsulinemia, and atherosclerosis. Moreover,
these complexes are known to increase the risk of cardiovascular
disease (CVD; 1). In particular, the accumulation of adipose
tissue predominantly in the visceral cavity plays a major role in
the development of metabolic syndrome, CVD, or both (2).
Therefore, estimating the visceral fat accumulation is impor-
tant in terms of evaluating patients with a higher risk of CVD.
Currently, computed tomography (CT) at the abdominal level is
recognized as the standard method (3). However, exposure to
ionizing radiation, high cost, and low availability prevent the
wide use of CT in clinical and epidemiologic studies. Therefore,
alternative, simple, noninvasive methods of assessing visceral
fat accumulation are needed. Such methods would include the
anthropometric indexes, such as the body mass index (BMI; in
kg/m2), waist circumference, and the waist-to-hip circumference
ratio (WHR; 4); dual-energy X-ray absorptiometry (5); and ul-
trasonography (6–9). Ultrasonography is a reliable and conve-
nient way of quantifying the amount of visceral fat, and the
diverse ultrasonographic values were reported to be useful (6–
11). Nevertheless, the absence of a useful measurement with
established simplicity and reliability prevents the widespread use
of ultrasonography. In addition, whether the ultrasonographi-
cally determined amount of visceral fat directly reflects the risk
of CVD, other metabolic diseases (eg, hypertension, dyslipide-
mia, and metabolic syndrome), or both remains to be proven.
To assess the usefulness of ultrasonographic measurement for
visceral fat, we investigated the correlation between the values
measured with CT and with ultrasonography and the correlation
between several ultrasonographic values and the risk factors of
CVD. This study particularly focused on whether the visceral fat
thickness (VFT) measured by ultrasonography could be an al-
ternative index for estimating the risk of CVD and whether it
could predict the presence of coronary artery disease (CAD) or
other metabolic diseases.
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SUBJECTS AND METHODS
Subjects
Three hundred forty-six diabetic patients (240 men and 106
women) who visited the Diabetes Center at the Severance Hos-
pital, Yonsei University, for glycemia control were enrolled in
the study. The exclusion criteria included pregnancy; endocri-
nopathies other than diabetes; a history of treatment with anti-
obesity drugs, thiazolidinediones, or corticosteroid; abnormal
renal function as determined from the age-adjusted creatinine-
clearance values; symptoms that are indicative of CAD within
the previous 6 mo; abnormal electrocardiogram findings without
a confirmation by angiography; and weight loss of 3 kg during
the past 3 mo.
All the participants underwent the standard examination and
testing, which included measurement of the concentrations of
fasting glucose, total cholesterol, HDL cholesterol, triacylglyc-
erol, high-sensitivity C-reactive protein (hsCRP), and insulin;
blood pressure, height, weight, and waist and hip circumference
measurements (by the same investigator); a resting electrocar-
diogram; and completion of a questionnaire on CVD and other
diseases. As an indicator of insulin resistance, this study used an
index for a homeostasis model assessment for insulin resistance
(HOMA-IR), which was calculated as follows:
HOMA-IR  [fasting plasma glucose (mmol/L) 
fasting serum insulin (U/mL)]/22.5 (1)
The body fat distribution for all participants was estimated by
ultrasonography, and CT scan was performed on only 75 of the
subjects (50 men and 25 women). The study was approved by the
Ethics Committee of Yonsei University College of Medicine,
and written informed consent was obtained from each subject.
Anthropometric data
The height and weight were measured to the nearest 0.1 cm and
0.1 kg, respectively, while the subjects were wearing light cloth-
ing and not wearing shoes. The waist circumference was mea-
sured at the midpoint between the lateral iliac crest and the lowest
rib, and the hip circumference was measured at the maximal
protrusion of the greater trochanter.
Ultrasonography was performed by using a high-resolution
ultrassonographic system (SA 9900; Medison, Seoul, Korea) as
described by Suzuki et al (10) and Armellini et al (11). Briefly,
the subjects were examined in the supine position. All frozen
images were obtained immediately after respiration to avoid the
influence of the respiratory status or abdominal wall tension. The
maximum thickness of the preperitoneal fat (PFTmax) and the
minimum thickness of the subcutaneous fat (SFTmin) were mea-
sured by longitudinal scanning with the use of a 7.5-MHz linear
probe from the xiphoid process to the umbilicus along the linea
alba. The preperitoneal fat thickness was defined as the thickness
of the fat tissue between the liver surface and the linea alba, and
the subcutaneous fat thickness was defined as the thickness of the
fat tissue between the skin-fat interface and the linea alba. There-
after, transverse scanning was performed to measure the maxi-
mum subcutaneous fat thickness (SFTmax) by using a 7.5- MHz
probe and to measure VFT by using a 3.5-MHz probe; both
measures were obtained 1 cm above the umbilicus. VFT was
defined as the distance between the anterior wall of the aorta and
the internal face of the rectoabdominal muscle perpendicular to
the aorta. The ratio of PFTmax to SFTmin was calculated and is
referred to as the abdominal wall fat index (AFI). The ratio of
VFT to SFTmax was calculated as the value corresponding to the
CT-determined ratio of visceral fat area (VFA) to subcutaneous
fat area (SFA) (VSR).
CT scanning was carried out on the same day as ultrasonog-
raphy. The CT scans were performed (Tomoscan 350; Philips,
Mahway, NJ) to measure the VFA and SFA at L4–L5 and the
muscle and fat areas at midthigh (the midpoint of the upper
border of the patella and the greater trochanter). Adipose tissue
was defined as having a density of 150 to 50 Hounsfield
units, and muscle tissue was defined as having a density of49
to 100 Hounsfield units (12). The VSR and the ratio of the VFA
to the muscle area (VMR) were calculated.
The bilateral common carotid arteries (CCAs) were scanned
by using the SA9900 system (Medison) with a 7.5-MHz linear
transducer. Scanning was performed at the far wall of the middle
and distal CCAs by using a lateral longitudinal projection. The
intima-media thickness (IMT) at the CCA, which is defined as
the distance between the media-adventitia interface and the
lumen-intima interface, was measured at the point of the greatest
thickness and at 1 cm upstream and 1 cm downstream of that
point with the use of a Digimatic electronic caliper (Mitutoyo,
Kawasaki, Japan). The mean IMT was defined as the mean of 6
measurements, and the maximum IMT was defined as the largest
of 6 measurements. The same investigator performed all the
ultrasonographic procedures used to estimate the fat distribution
and the IMT.
Definition of terms
As detailed in the report of the Adult Treatment Panel III (13),
metabolic syndrome was defined the presence of2 of the con-
ditions hypertriacylglycerolemia, low-HDL cholesterolemia,
and hypertension. Dyslipidemia was defined as hypertriacyl-
glycerolemia ( 1.7 mmol/L, or 150 mg/dL), low-HDL cho-
lesterolemia ( 1.0 mmol/L, or  40 mg/dL, in men;  1.3
mmol/L, or 50 mg/dL, in women), or receipt of hypolipidemic
treatment. Hypertension was defined as a systolic blood pressure
of 130 mm Hg and a diastolic blood pressure of 85 mm Hg,
and the use of antihypertensive agents was also considered to
indicate hypertension. In this study, abdominal obesity was not
included in the component of metabolic syndrome because sub-
jects with a larger waist circumference have a longer VTF, and
that fact might bias the results.
Analytic methods
The serum glucose concentrations were determined by using
the glucose oxidase method. The plasma insulin concentrations
were measured by using a radioimmunoassay according to a
double-antibody method and with a commercially available ra-
dioimmunoassay kit (Linco Research Inc, St Charles, MO). The
serum cholesterol and triacylglycerol concentrations were mea-
sured enzymatically. The hsCRP concentration was quantified
by using a Nephelometer II (Dade Behring Diagnostics, Mar-
burg, Germany; 14).
Statistical analysis
Statistical analyses were performed by using SPSS software
(version 10.0; SPSS Inc, Chicago) and were carried out sepa-
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rately in men and women because of the significant difference in
body fat distribution between the sexes. The associations be-
tween the continuous variables were determined by using Pear-
son’s correlation coefficients. The intergroup comparisons were
performed by using an independent-sample t test and a one-way
analysis of variance followed by Scheffe’s post hoc test. The
prevalence and risk relation of CAD or the other metabolic dis-
eases among the groups were compared by using a chi-square
test. Logistic regression, which was adjusted for age, waist cir-
cumference, and BMI, was used to analyze the associations be-
tween the tertiles of the VFT and the presence of CAD or other
metabolic diseases. A low tertile of VFT was used as the refer-
ence category [odds ratio (OR): 1.00]. Receiver operating char-
acteristic (ROC) curve analyses were performed to determine the
sensitivity and specificity of using VFT as a forecaster of meta-
bolic syndrome. P values 0.05 were considered significant.
RESULTS
Clinical characteristics of the subjects
The subjects were classified by the tertile on the basis of their
VFT; the mean values are  44.1 mm in men and  36 mm in
women for the low tertile, 44.1–58.0 mm in men and 36.0–47.0
mm in women for the middle tertile, and 58.0 mm in men and
 47.0 mm in women for the high tertile. The patients’ charac-
teristics according to VFT tertiles are shown in Table 1. No
differences in terms of age, SFTmax, concentrations of fasting
glucose or glycated hemoglobin (Table 1), duration of diabetes,
or systolic and diastolic blood pressures (data not reported) were
observed between the tertiles in the men or the women. The
weight, waist circumference, and BMI increased from the low
tertile to the middle tertile and the high tertile. In the men, the
fasting serum concentrations of triacylglycerol, hsCRP, and in-
sulin; the ratio of serum triacylglycerol to HDL cholesterol;
HOMA-IR; and the mean IMT in the high tertile group were
higher than those in the low tertile group. Women in the high VFT
tertile had higher fasting serum triacylglycerol and hsCRP con-
centrations, higher triacylglycerol:HDL, and a lower HDL-
cholesterol concentration than did those in the low tertile.
Correlations of values measured by CT and
ultrasonography in 75 subjects
To test the usefulness of ultrasonography for evaluating ab-
dominal adiposity, this study first compared the values obtained
by ultrasonography with those obtained by CT scan in 75 subjects
selected from the study population. The 75 subjects did not differ
significantly from the entire population in anthropometric and
biochemical characteristics (data not shown).
The anthropometric characteristics of the 75 subjects who
underwent CT scanning are listed in Table 2. No differences in
age, BMI, waist circumference, WHR, or the total abdominal fat
area were observed between the men and the women. Neverthe-
less, the men had less subcutaneous fat deposition and a higher
VSR than did the women. These differences identified by CT
scan were also observed in the ultrasonographic assessment.
This study investigated the correlations between values ob-
tained by using CT scanning (VFA, VSR, and VMR) and those
obtained by using ultrasonography (VFT, PFTmax, AFI, and
VFT:SFTmax; Table 3). The VFT correlated with the VFA (r
0.799, P 0.001), VSR, and VMR. The VFT:SFTmax was well
correlated with the VFA (r 0.473, P 0.05), VSR, and VMR.
TABLE 1
Clinical characteristics of the subjects by tertile of visceral fat thickness1
Men Women
Low tertile
(n 78)
Middle tertile
(n 81)
High tertile
(n 81)
P for
trend
Low tertile
(n 35)
Middle tertile
(n 34)
High tertile
(n 37)
P for
trend
Age (y) 47.9 12.8 49.9 11.8 51.5 11.0 NS 52.2 11.3 53.7 7.5 55.0 5.9 NS
Weight (kg) 66.6 9.8 71.8 8.82 76.5 9.53,4  0.001 58.1 8.3 59.6 7.1 66.0 9.53  0.05
Waist (cm) 83.3 6.6 87.7 5.73 92.7 6.83,5  0.001 79.8 10.5 83.7 7.1 90.4 7.63  0.001
BMI (kg/m2) 23.2 2.5 24.7 2.62 27.0 3.03,5  0.001 23.3 3.1 24.4 2.2 26.8 3.53  0.001
SFTmax (mm) 20.8 7.5 20.9 7.0 19.5 7.9 NS 25.4 8.4 25.4 8.4 26.6 6.4 NS
Glucose (mmol/L) 7.94 3.39 7.88 2.61 8.10 2.50 NS 8.60 2.94 7.78 3.39 8.94 2.50 NS
Hb A1c (%) 7.9 1.9 7.7 1.5 7.8 1.6 NS 7.7 1.5 7.5 1.2 8.2 1.7 NS
Total cholesterol (mmol/L) 4.73 0.83 4.71 0.93 4.66 0.85 NS 4.55 0.75 4.66 0.80 4.86 0.70  0.05
HDL cholesterol (mmol/L) 1.15 0.18 1.11 0.19 1.08 0.19 NS 1.31 0.22 1.15 0.20 1.11 0.212  0.05
Triacylglycerol (mmol/L) 3.46 1.50 4.96 1.982 5.25 2.113  0.05 3.10 1.19 4.42 2.172 4.86 2.062  0.05
Triacylglycerol:HDL cholesterol 3.32 1.92 5.15 4.262 6.13 4.452  0.001 2.7 1.8 4.7 4.82 4.9 2.52  0.05
hsCRP (mg/L) 1.50 1.12 1.57 0.96 2.1 1.852,4  0.05 0.71 1.59 0.93 0.60 1.52 1.12,4  0.05
Insulin (pmol/L) 46.6 32.3 50.2 29.4 71.8 342,4  0.05 57.4 44.4 61.7 30.8 68.2 36.6 NS
HOMA-IR 2.4 1.3 2.5 1.4 3.5 2.12,4  0.05 2.9 2.7 3.1 2.1 3.5 1.7 NS
IMTmean (mm) 0.68 0.14 0.74 0.12 0.84 0.202  0.05 0.70 0.21 0.69 0.11 0.71 0.10 NS
IMTmax (mm) 0.88 0.23 0.94 0.20 1.06 0.21 NS 0.85 0.29 0.89 0.26 0.86 0.10 NS
1 All values are xSD. Mean values for tertiles of visceral fat thickness were 36.2 mm (95% CI: 10.9, 44.0 mm) and 31.8 mm (15.0, 36.0 mm) (low tertile),
53.3 mm (44.1, 57.9 mm) and 44.7 mm (37.1, 47.0 mm) (middle tertile), and 75.8 mm (58.5, 104.0 mm) and 63.6 mm (47.4, 98.0 mm) (high tertile) in the men
and the women, respectively. SFTmax, maximum subcutaneous fat thickness; Hb A1c, glycated hemoglobin; hsCRP, high-sensitivity C-reactive protein;
HOMA-IR, homeostasis model assessment for insulin resistance; IMTmean and IMTmax, mean and maximum intima-media thickness at the common carotid
artery, respectively.
2,3 Significantly different from the low tertile (one-way ANOVA followed by Scheffe’s post hoc test): 2P 0.05, 3 P 0.001.
4,5 Significantly different from the middle tertile (one-way ANOVA followed by Scheffe’s post hoc test): 4P 0.05, 5 P 0.001.
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In contrast, the correlation of waist circumference with VFA (r
0.543, P 0.05) was weaker than that with the VFT.
Coefficients of variation of the ultrasonographic values
The intraobservational reproducibility of the ultrasonographic
estimations was 1.5–2.0% for the VFT, 1.8–3.2% for the SFTmax
and SFTmin, and 3.0–5.2% for the PFTmax. The reproducibility
between the 2 operators was 1.8–2.8% for the VFT and 3.5–
8.1% for the other indexes. Therefore, the absolute value of the
VFT might be a more useful marker of visceral fat deposition
than might either the PFTmax, AFI, or VFT:SFTmax.
Correlations between several ultrasonographic values and
clinical and laboratory data
The correlation coefficients between the ultrasonographic val-
ues and the clinical data are shown in Table 4. In the men, VFT
correlated with BMI; waist circumference; concentrations of se-
rum HDL cholesterol (negatively), triacylglycerol, hsCRP, and
insulin; triacylglycerol:HDL cholesterol; HOMA-IR; and the
mean and maximum IMT. In addition, VFT correlated with BMI,
waist circumference, triacylglycerol and hsCRP concentrations,
triacylglycerol:HDL cholesterol, and HOMA-IR in the women.
Waist circumference correlated with triacylglycerol (r0.24,
P 0.05), HDL-cholesterol (r0.17, P 0.05), and insulin
(r 0.27, P 0.05) concentrations; triacylglycerol:HDL choles-
terol (r 0.24, P 0.001); HOMA-IR (r 0.27, P 0.05); and
mean IMT (r 0.20, P 0.05) in men. However, the correlation
coefficients between waist circumference and the above risk factors
were lower than those between VFT and the above risk factors.
Association between VFT and the prevalence of CAD and
metabolic diseases
Next, this study compared the prevalence of CAD, hyperten-
sion, dyslipidemia (hypertriacylglycerolemia, low-HDL choles-
terolemia, or both), and metabolic syndrome in the men and the
women according to VFT tertile (Table 5). Men in the middle
and high VFT tertiles had a greater prevalence of CAD, hyper-
triacylglycerolemia, low-HDL cholesterolemia, and metabolic
syndrome than did those in the low tertile. In women, the prev-
alence of dyslipidemia and metabolic syndrome was higher in the
middle and high tertiles than in the low tertile. However, the
prevalence of CAD did not differ significantly among tertiles.
The logistic regression results showing the ORs for the various
metabolic diseases in the VFT tertiles are listed in Table 6. The
ORs for CAD, hypertension, hypertriacylglycerolemia, low-
HDL cholesterolemia, and metabolic syndrome were higher for
men in the middle and high tertiles than for those in the low
tertile. The ORs for dyslipidemia and metabolic syndrome were
higher for women in the middle and high tertiles than for those in
the low tertile. With the exception of hypertension and low-HDL
cholesterolemia in the men and hypertriacylglycerolemia in the
women in the high VFT tertile, these observations remained
significant after adjustment for age, waist circumference, and
BMI.
As shown in Figure 1, the area under the ROC curve for VFT
as a predictor of the presence of metabolic syndrome was 0.764
(95% CI: 0.700, 0.827; P  0.001) in men and 0.730 (95% CI:
0.614, 0.845; P 0.001) in the women. A VFT of 47.6 and 35.5
mm in the men and the women, respectively, was found to be the
discriminating cutoff for the metabolic syndrome (specificity of
74% and 78% and sensitivity of 71% and 69% in the men and in
the women, respectively). The use of ROC analyses to predict the
presence or absence of CAD, other metabolic diseases, or both
showed that the area under the curves for VFT were 0.621 (95%
CI: 0.527, 0.714) for CAD, 0.649 (95% CI: 0.572, 0.725) for
hypertension, 0.725 (95% CI: 0.657, 0.793) for hypertriacyl-
glycerolemia, and 0.583 (95% CI: 0.507, 0.659) for low-HDL
cholesterolemia in the men and 0.687 (95% CI: 0.577, 0.799) for
hypertriacylglycerolemia and 0.695 (95% CI: 0.544, 0.803) for
low-HDL cholesterolemia in the women.
TABLE 2
Anthropometric indexes in the 75 patients who underwent computed
tomography1
Men (n 50) Women (n 25)
Age (y) 45.7 9.8 46.7 10.3
Weight (kg) 73.7 12.1 61.1 14.12
BMI (kg/m2) 25.3 3.8 24.1 3.8
Waist (cm) 88.0 7.8 84.2 11.2
WHR 0.93 0.04 0.93 0.07
Computed tomography
Total fat area (cm2) 225.1 66.2 258.5 81.7
VFA (cm2) 95.4 29.7 82.5 28.1
SFA (cm2) 129.7 48.7 175.9 66.32
VSR 0.79 0.28 0.51 0.182
Ultrasonography
VFT (mm) 51.7 15.4 37.1 18.22
SFTmax (mm) 22.4 8.0 30.1 9.82
AFI 1.91 1.19 0.84 0.312
VFT:SFTmax 2.56 1.00 1.31 0.752
1 All values are x  SD. WHR, waist-to-hip circumference ratio; VFA,
visceral fat area; SFA, subcutaneous fat area; VSR, visceral-to-subcutaneous
fat area ratio; VFT, visceral fat thickness; SFTmax, the maximum subcuta-
neous fat thickness; AFI, abdominal wall fat index (ratio of maximum pre-
peritoneal fat thickness to minimum subcutaneous fat thickness).
2 Significantly different from the men, P 0.05 (independent-sample t
test).
TABLE 3
Pearson’s correlation coefficients between the values measured by
computed tomography (CT) and by ultrasonography1
Ultrasonography
CT scan
VFA VSR VMR
VFT 0.7992 0.3863 0.6113
PFTmax 0.3283 0.136 0.117
AFI 0.101 0.5023 0.303
VFT:SFTmax 0.4733 0.5712 0.5842
1 75 patients underwent CT. VFA, visceral fat area; VSR, visceral-to-
subcutaneous fat area ratio; VMR, visceral fat-to-thigh muscle area ratio;
VFT, visceral fat thickness; PFTmax, maximum preperitoneal fat thickness;
AFI, abdominal wall fat index (ratio of maximum preperitoneal fat thickness
to minimum subcutaneous fat thickness); VFT:Smax, ratio of VFT to maxi-
mum subcutaneous fat thickness.
2 P 0.001.
3 P 0.05.
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DISCUSSION
Previous studies reported that ultrasonography could be used
to estimate visceral adiposity (8–10). However, no definite val-
ues were established. This study showed that VFT had a better
correlation with the values measured by CT than did PFTmax,
AFI, or VFT:SFTmax and that VFT might be very useful in as-
sessing the amount of visceral fat accumulation. Furthermore,
this study found that a high VFT was closely related to an in-
creased risk of CVD and to a greater prevalence of CAD, other
metabolic diseases, or both in men. Therefore, this study empha-
sizes that an assessment of visceral fat amounts via ultrasonog-
raphy can be used to evaluate the risk of CVD and predict the
presence of various metabolic diseases.
Body fat distribution varies considerably, even among people
with similar total fat amounts. It is well known that visceral
obesity may be a better predictor of metabolic syndrome—
including hyperinsulinemia, glucose intolerance, dyslipidemia,
and CVD—and cancer than may general obesity (1, 15). In ad-
dition, subjects judged by the BMI criteria to be lean may be
insulin resistant if they have centrally located body fat (16).
Several methods of assessing the amount of visceral fat accu-
mulation have been investigated. The simplest way is to use an
anthropometric index such as BMI, waist circumference, WHR,
abdominal sagittal diameter (4), or neck circumference (17).
These values provide a fast, easy, and noninvasive method of
assessing regional adiposity, particularly in epidemiologic stud-
ies (18, 19). However, it is possible that substantial variations in
the visceral fat content may be observed among persons with a
similar waist circumference or WHR value because these in-
dexes are not the direct methods of quantifying the amount of fat
or of discriminating between visceral and subcutaneous fat. Ac-
cordingly, alternative and reliable methods are needed to over-
come these pitfalls of anthropometric indexes.
Although ultrasonography is not a method normally used to
quantify the amount of fat, this study suggests that it may be an
alternative method of assessing visceral adiposity. Furthermore,
the ORs for CAD [ORs: 4.48 (95% CI: 1.29, 5.51) and 2.04 (95%
CI: 1.06, 3.94); P0.016], hypertriacylglycerolemia [ORs: 2.87
(95% CI: 1.41, 5.86) and 1.91 (95% CI: 1.24, 2.95); P 0.003],
and metabolic syndrome [ORs: 3.38 (95% CI: 1.61, 7.10) and
1.95 (95% CI: 1.16, 3.27); P 0.003] in the men in the middle
and high VFT tertiles, respectively, were significantly higher
than those in the men in the low tertile, even after adjustment for
age, waist circumference, and BMI. In addition, the VFT corre-
lated with several risk factors for CVD, such as the fasting plasma
triacylglycerol, hsCRP, and insulin concentrations; triacylglyc-
TABLE 4
Pearson’s correlation coefficients between several ultrasonographic values and the clinical or laboratory data1
Men (n 240) Women (n 106)
VFT Pmax AFI VFT:SFTmax VFT Pmax AFI VFT:SFTmax
BMI 0.612 0.332 0.08 0.143 0.602 0.25 0.273 0.05
Waist circumference 0.622 0.292 0.06 0.203 0.562 0.18 0.263 0.12
Total cholesterol 0.03 0.07 0.04 0.05 0.25 0.10 0.18 0.11
HDL cholesterol 0.303 0.15 0.07 0.153 0.17 0.20 0.11 0.09
Triacylglycerol 0.392 0.03 0.09 0.13 0.333 0.09 0.07 0.08
Triacylglycerol:HDL cholesterol 0.402 0.09 0.05 0.14 0.313 0.05 0.12 0.06
hsCRP 0.342 0.14 0.14 0.02 0.442 0.22 0.13 0.12
Fasting insulin 0.333 0.01 0.12 0.08 0.21 0.11 0.03 0.10
HOMA-IR 0.312 0.10 0.07 0.10 0.303 0.11 0.08 0.08
IMTmean 0.333 0.17 0.02 0.303 0.28 0.16 0.24 0.33
IMTmax 0.243 0.11 0.09 0.233 0.15 0.27 0.453 0.15
1 VFT, visceral fat thickness; PFTmax, the maximum preperitoneal fat thickness; AFI, abdominal wall fat index (ratio of maximum preperitoneal fat
thickness to minimum subcutaneous fat thickness); VFT:SFTmax, ratio of VFT to SFT; hsCRP, high-sensitivity C-reactive protein; HOMA-IR, homeostasis
model assessment for insulin resistance; IMTmean and IMTmax, mean and maximum intima-media thickness at the common carotid artery, respectively.
2 P 0.001.
3 P 0.05.
TABLE 5
Prevalence of coronary artery disease (CAD) and metabolic diseases within the visceral fat thickness tertiles in the male and female subjects1
Prevalence
Men Women
Low tertile
(n 78)
Middle tertile
(n 81)
High tertile
(n 81)
Low tertile
(n 35)
Middle tertile
(n 34)
High tertile
(n 37)
CAD (%) 5.4 17.92 21.62 2.9 12.9 9.1
Hypertension (%) 50.0 65.4 79.73 64.7 67.7 60.6
Hypertriacylglycerolemia (%) 35.1 66.73 77.03 35.3 67.72 69.72
Low-HDL cholesterolemia (%) 40.5 60.32 60.82 52.9 87.12 90.93
Metabolic syndrome (%) 35.9 72.83 86.43 57.1 82.42 94.63
1 The definitions of hypertension, hypertriacylglycerolemia, low-HDL cholesterolemia, and metabolic syndrome are given in the Definition of terms
subsection of Subjects and Methods. CAD confirmed by angiography.
2,3 Significantly different from the low tertile (chi-square analysis): 2P 0.05, 3 P 0.001.
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erol:HDL cholesterol; and HOMA-IR. These correlations with
VFT were relatively stronger than were those with the waist
circumference or other ultrasonographic values. Moreover, the
mean and maximum IMTs at the CCA, which are a marker of
early atherosclerosis, correlated with VFT (r  0.33 and 0.24,
respectively; P  0.05) and VFT:SFTmax (r  0.30 and 0.23,
respectively; P  0.05) in men, but did not correlate with the
other anthropometric and imaging values, except for waist cir-
cumference, which showed a weak correlation with the mean
IMT (r 0.20, P 0.05).
In addition, this study suggested that a VFT of 47.6 and 35.5
mm in the men and the women, respectively, was a cutoff for
predicting the presence of CAD and various metabolic diseases.
In the case of metabolic syndrome, these cutoff values for VFT
were shown to have high specificity and sensitivity in both sexes.
Therefore, the ultrasonographic measurement of VFT might be a
good method of predicting CAD, metabolic diseases, or both and
of evaluating the risk of CVD without the limitations of the
anthropometric indexes.
Although the PFTmax measured by ultrasonography was pre-
viously reported to correlate positively with the VFA measured
by CT (10), we did not observe this correlation. This discrepancy
may result from the irreproducibility of the PFTmax measure-
ments or from differences in the measuring sites. The sites were
not fixed because PFTmax was measured at the thickest point in
the preperitoneal fat. Therefore, it is likely that PFTmax has a high
degree of irreproducibility and that it may be an unadvisable
measure in clinical or epidemiologic studies. In the present study,
the intraobservational and interobservational CVs for VFT were
lower (1.5–2.0% and 1.8–3.0%, respectively) than those for the
other ultrasonographic measurements (1.8–5.2% and 3.5–8.1%,
respectively). In addition, VFT had a better correlation with VFA
TABLE 6
Odds ratios and 95% CIs of coronary artery disease (CAD) and the metabolic diseases by tertile of visceral fat thickness1
Low tertile
Unadjusted Adjusted2
Middle tertile High tertile P for trend Middle tertile High tertile P for trend
Men (n 240)
CAD 1.00 3.83 (1.20, 12.23)3 4.83 (1.53, 15.24)4 0.006 4.48 (1.29, 5.51)3 2.04 (1.06, 3.94)3 0.016
Hypertension 1.00 1.89 (0.98, 3.63) 3.93 (1.90, 8.14)4  0.001 1.46 (0.70, 3.06) 1.40 (0.88, 2.23) 0.096
Hypertriacylglycerolemia 1.00 3.69 (1.89, 7.21)4 6.19 (3.01, 12.74)4  0.001 2.87 (1.41, 5.86)3 1.91 (1.24, 2.95)3 0.003
Low-HDL cholesterolemia 1.00 2.22 (1.16, 4.26)3 2.28 (1.18, 4.40)3 0.014 1.77 (0.88, 3.53) 1.36 (0.90, 2.05) 0.18
Metabolic syndrome 1.00 4.43 (2.24, 8.78)4 11.14 (4.92, 25.23)4  0.001 3.38 (1.61, 7.10)3 1.95 (1.16, 3.27)3 0.003
Women (n 106)
CAD 1.00 4.89 (0.52, 46.36) 3.30 (0.33, 33.46) 0.19 4.68 (0.48, 45.14) 1.57 (0.42, 5.88) 0.21
Hypertension 1.00 1.45 (0.41, 3.21) 0.84 (0.31, 2.26) 0.30 0.95 (0.30, 3.03) 0.67 (0.36, 41.28) 0.35
Hypertriacylglycerolemia 1.00 3.85 (1.37, 10.79)3 4.22 (1.52, 11.73)3 0.003 3.91 (1.33, 11.48)3 1.71 (0.95, 3.09)  0.05
Low-HDL cholesterolemia 1.00 6.00 (1.72, 20.89)4 8.89 (2.27, 34.79)4 0.014 5.32 (1.48, 19.09)3 2.81 (1.33, 5.97)3  0.50
Metabolic syndrome 1.00 4.73 (1.35, 16.54)3 22.4 (2.73, 98.92)4  0.001 3.25 (1.19, 11.03)3 10.74 (1.12, 67.83)3  0.05
1 The definitions of hypertension, hypertriacylglycerolemia, low-HDL cholesterolemia, and metabolic syndrome are given in the Definition of terms
subsection of Subjects and Methods. CAD confirmed by angiography.
2 Adjusted for age, waist circumference, and BMI.
3,4 Significantly different from the low tertile (logistic regression analysis): 3P 0.05, 4 P 0.001.
FIGURE 1. Receiver operating characteristic (ROC) analyses of visceral fat thickness as a predictor of the presence or absence of the metabolic syndrome
in men (left) and women (right). The higher the area under the curve—ie, the greater the curvature away from the 50% line—the greater the predictive power.
A visceral fat thickness of 47.6 and 35.5 mm in men and women, respectively, was chosen as the discriminator value to predict the presence of the metabolic
syndrome (specificity of 74% and 78% and sensitivity of 71% and 69% in the men and the women, respectively). The area under the ROC curve was 0.764 in
the men and 0.730 in the women.
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(r  0.799, P  0.001) than with the other ultrasonographic
values and with waist circumference. Therefore, VFT appears to
be more reliable in estimating the amount of visceral fat accu-
mulation than are the other ultrasonographic indexes.
This study had several limitations. First, it was performed only
in a Korean population. Accordingly, the VFT cutoffs used for
predicting the presence of CAD, metabolic diseases, or both may
differ from those in other ethnic groups. Second, because all the
participants were diabetic and almost every patient was being
treated with oral hypoglycemic, antihypertensive, or hypolipi-
demic agents, all of which are capable of affecting the serum lipid
concentration and insulin sensitivity, it is possible that the inter-
relations between VFT and the metabolic values related to the
risks of CVD were weakened. We believe that, had healthy sub-
jects been used in this study, a more conspicuous relation be-
tween VFT and the CVD risk would have been found. Third,
whereas VFT in the men reasonably reflected CVD risk, it did not
do so in the women. The divergent significances of VFT accord-
ing to the sex appear to be due to the lower prevalence of CAD in
Korean women than in men. In addition, this study did not ana-
lyze the role of VFT in the women after grouping them according
to premenopausal and postmenopausal states. Accordingly, ad-
ditional work will be needed to validate the value of using VFT
in women.
In conclusion, VFT measured by ultrasonography was
strongly correlated with the amount of visceral fat and the risk
factors associated with CVD. A higher VFT was found to inde-
pendently predict CAD and metabolic diseases in the men.
Therefore, we believe that VFT is a more useful index than are the
other ultrasonographic values or anthropometric indexes, not
only for assessing visceral obesity but also for screening patients,
particularly men, with a higher risk of CAD, metabolic diseases,
or both.
We thank the study subjects for their participation in this study.
SKK performed the study design, data collection, ultrasonographic mea-
surements, and statistical data analysis, and he wrote the manuscript. HJK
and KYH performed the data collection and were responsible for quality
control of the ultrasonographic measurements. SHC and CWA supervised
the data collection. SKL, KRK, and HCL provided significant expertise and
reviewed the manuscript. KBH provided the conception for the study. BSC
contributed to the design and conduct of this study and provided critical
revision of the manuscript. None of the authors had any financial, personal,
or professional conflict of interest.
REFERENCES
1. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin
G. Abdominal adipose tissue distribution, obesity, and risk of cardio-
vascular disease and death: 13-year follow-up of participants in the study
of men born in 1913. Br Med J 1984;288:1401–4.
2. Fujioka S, Matsuzawa Y, Tokunaga K, Tauri S. Contribution of intra-
abdominal fat accumulation to the impairment of glucose and lipid
metabolism in human obesity. Metabolism 1987;36:54–9.
3. Rossner S, Bo WJ, Hiltbrandt E, et al. Adipose tissue determinations in
cadavers: a comparison between cross-sectional planimetry and com-
puted tomography. Int J Obes Relat Metab Disord 1990;14:893–902.
4. Seidell JC, Cigolini M, Charzewska J, Ellsinger BM, Deslypere JP, Cruz
A. Fat distribution in European men: a comparison of anthropometric
measurements in relation to cardiovascular risk factors. Int J Obes Relat
Metab Disord 1992;16:17–22.
5. Bertin E, Marcus C, Ruiz JC, Eschard JP, Leutenegger M. Measurement
of visceral adipose tissue by DXA combined with anthropometry in
obese humans. Int J Obes Relat Metab Disord 2000;24:263–70.
6. Tornaghi G, Raiteri R, Pozzato C, et al. Anthropometric or ultrasonic
measurements in assessment of visceral fat? A comparative study. Int J
Obes Relat Metab Disord 1994;18:771–5.
7. Armellini F, Zamboni M, Robbi R, et al. Total and intra-abdominal fat
measurements by ultrasound and computerized tomography. Int J Obes
Relat Metab Disord 1993;17:209–14.
8. Ribeiro-Filho FF, Faria AN, Kohlmann O Jr, et al. Ultrasonography for
the evaluation of visceral fat and cardiovascular risk. Hypertension
2001;38:713–7.
9. Stolk RP, Meijer R, Mali WP, Grobbee DE, van der Graaf Y. Ultrasound
measurements of intraabdominal fat estimate the metabolic syndrome
better than do measurements of waist circumference. Am J Clin Nutr
2003;77:857–60.
10. Suzuki R, Watanabe S, Hirai Y, et al. Abdominal wall fat index, esti-
mated by ultrasonography, for assessment of the ratio of visceral fat to
subcutaneous fat in the abdomen. Am J Med 1993;95:309–14.
11. Armellini F, Zamboni M, Rigo L, et al. Sonography detection of small
intra-abdominal fat variations. Int J Obes Relat Metab Disord 1991;15:
847–52.
12. Ashwell M, Cole TJ, Dixon AK. Obesity: new insight into the anthro-
pometric classification of fat distribution shown by computed tomogra-
phy. Br Med J 1985;292:1692–4.
13. Executive summary of the third report of the National Cholesterol Ed-
ucation Program (NCEP) expert panel on detection, evaluation, and
treatment of high blood cholesterol in adults (Adult Treatment Panel III).
JAMA 2001;285:2486–97.
14. van der Meer IM, de Maat MP, Kiliaan AJ, van der Kuip DA, Hofman A,
Witteman JC. The value of C-reactive protein in cardiovascular risk
prediction: the Rotterdam Study. Arch Intern Med 2003;163:1323–8.
15. Bjorntorp P. Portal adipose tissue as a generator of risk factors for
cardiovascular disease and diabetes. Arteriosclerosis 1990;10:493–6.
16. Kahn SE, Prigeon RL, Schwartz RS, et al. Obesity, body fat distribution,
insulin sensitivity and islet beta-cell function as explanations for meta-
bolic diversity. J Nutr 2001;131:354S–60S.
17. Laakso M, Matilainen V, Keinanen-Kiukaanniemi S. Association of
neck circumference with insulin resistance-related factors. Int J Obes
Relat Metab Disord 2002;26:873–5.
18. Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and
abdominal sagittal diameter; best simple anthropometric indexes of ab-
dominal visceral adipose tissue accumulation and related cardiovascular
risk in men and women. Am J Cardiol 1994;73:460–8.
19. Lemieux S, Prud’homme D, Tremblay A, Bouchard C, Despress JP.
Anthropometric correlates to changes in visceral adipose tissue over 7
years in women. Int J Obes Relat Metab Disord 1996;20:618–24.
ULTRASONOGRAPHIC ASSESSMENT OF VISCERAL FAT 599
 at YO
NSEI UNIVERSITY CO
LLEG
E O
F M
EDICINE on June 2, 2015
ajcn.nutrition.org
D
ow
nloaded from
 
